Technical Analysis for THAR - Tharimmune, Inc.

Grade Last Price % Change Price Change
D 2.50 2.88% 0.07
THAR closed up 2.88 percent on Wednesday, November 20, 2024, on 11 percent of normal volume. It was able to find support at its 50 day moving average.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
50 DMA Support Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Crossed Above 20 DMA Bullish 2.88%
Crossed Above 50 DMA Bullish 2.88%
Pocket Pivot Bullish Swing Setup 2.88%
Wide Bands Range Expansion 2.88%
Oversold Stochastic Weakness 2.88%

   Recent Intraday Alerts

Alert Time
20 DMA Support about 22 hours ago
50 DMA Support about 22 hours ago
Down 3% about 22 hours ago
Down 2 % about 22 hours ago
Down 1% about 22 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Tharimmune, Inc. is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or "uncontrollable itching" in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting unique epitopes with novel mechanisms of action against well-known, validated targets in multiple solid tumors. Tharimmune has a license agreement with OmniAb, Inc. to access the company's antibody discovery technology platform against specified targets.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Immunology Solid Tumors Autoimmune Disease Antibodies Oncology Cancer Immunotherapy Antibody Hepatology Inflammatory Primary Biliary Cholangitis

Is THAR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 71.8485
52 Week Low 1.835
Average Volume 1,516,320
200-Day Moving Average 4.08
50-Day Moving Average 2.42
20-Day Moving Average 2.43
10-Day Moving Average 2.31
Average True Range 0.40
RSI (14) 52.83
ADX 29.65
+DI 31.73
-DI 21.74
Chandelier Exit (Long, 3 ATRs) 5.19
Chandelier Exit (Short, 3 ATRs) 3.05
Upper Bollinger Bands 3.18
Lower Bollinger Band 1.68
Percent B (%b) 0.55
BandWidth 61.98
MACD Line -0.01
MACD Signal Line -0.01
MACD Histogram -0.0017
Fundamentals Value
Market Cap 6.31 Million
Num Shares 2.53 Million
EPS -15.50
Price-to-Earnings (P/E) Ratio -0.16
Price-to-Sales 0.00
Price-to-Book 0.67
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.93
Resistance 3 (R3) 2.92 2.75 2.86
Resistance 2 (R2) 2.75 2.64 2.76 2.84
Resistance 1 (R1) 2.63 2.57 2.69 2.64 2.81
Pivot Point 2.46 2.46 2.50 2.47 2.46
Support 1 (S1) 2.34 2.35 2.40 2.36 2.19
Support 2 (S2) 2.17 2.28 2.18 2.16
Support 3 (S3) 2.05 2.17 2.14
Support 4 (S4) 2.07